91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global High Affinity Nerve Growth Factor Receptor Market Research Report 2023

Global High Affinity Nerve Growth Factor Receptor Market Research Report 2023

Publication ID: 
PB503240350
Publication Date: 
March 23, 2023
Pages: 
96
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Healthcare [2]
Pharma & Healthcare [3]
Description: 

Highlights
The global High Affinity Nerve Growth Factor Receptor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for High Affinity Nerve Growth Factor Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for High Affinity Nerve Growth Factor Receptor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for High Affinity Nerve Growth Factor Receptor in Bile Duct Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of High Affinity Nerve Growth Factor Receptor include Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc, Daiichi Sankyo Co Ltd, Dompe Farmaceutici SpA, Genzyme Corp, Handok Inc, Ignyta Inc and Loxo Oncology Inc, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for High Affinity Nerve Growth Factor Receptor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Affinity Nerve Growth Factor Receptor.
The High Affinity Nerve Growth Factor Receptor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global High Affinity Nerve Growth Factor Receptor market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High Affinity Nerve Growth Factor Receptor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc
Segment by Type
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others
Segment by Application
Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High Affinity Nerve Growth Factor Receptor companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 ASP-7962
1.2.3 AZD-7451
1.2.4 BNN-27
1.2.5 Cenegermin
1.2.6 CRB-0089
1.2.7 Others
1.3 Market by Application
1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Bile Duct Cancer
1.3.3 Papillary Thyroid Cancer
1.3.4 Low Back Pain
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High Affinity Nerve Growth Factor Receptor Market Perspective (2018-2029)
2.2 High Affinity Nerve Growth Factor Receptor Growth Trends by Region
2.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 High Affinity Nerve Growth Factor Receptor Historic Market Size by Region (2018-2023)
2.2.3 High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Region (2024-2029)
2.3 High Affinity Nerve Growth Factor Receptor Market Dynamics
2.3.1 High Affinity Nerve Growth Factor Receptor Industry Trends
2.3.2 High Affinity Nerve Growth Factor Receptor Market Drivers
2.3.3 High Affinity Nerve Growth Factor Receptor Market Challenges
2.3.4 High Affinity Nerve Growth Factor Receptor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue
3.1.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue (2018-2023)
3.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Players (2018-2023)
3.2 Global High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High Affinity Nerve Growth Factor Receptor Revenue
3.4 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio
3.4.1 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Affinity Nerve Growth Factor Receptor Revenue in 2022
3.5 High Affinity Nerve Growth Factor Receptor Key Players Head office and Area Served
3.6 Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
3.7 Date of Enter into High Affinity Nerve Growth Factor Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
4.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Type (2018-2023)
4.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2024-2029)
5 High Affinity Nerve Growth Factor Receptor Breakdown Data by Application
5.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Application (2018-2023)
5.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America High Affinity Nerve Growth Factor Receptor Market Size (2018-2029)
6.2 North America High Affinity Nerve Growth Factor Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2023)
6.4 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High Affinity Nerve Growth Factor Receptor Market Size (2018-2029)
7.2 Europe High Affinity Nerve Growth Factor Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2023)
7.4 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size (2018-2029)
8.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2018-2023)
8.4 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size (2018-2029)
9.2 Latin America High Affinity Nerve Growth Factor Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2023)
9.4 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size (2018-2029)
10.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2023)
10.4 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Company Detail
11.1.2 Array BioPharma Inc Business Overview
11.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Introduction
11.1.4 Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.1.5 Array BioPharma Inc Recent Development
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Company Detail
11.2.2 Astellas Pharma Inc Business Overview
11.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Introduction
11.2.4 Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.2.5 Astellas Pharma Inc Recent Development
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Detail
11.3.2 AstraZeneca Plc Business Overview
11.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Introduction
11.3.4 AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.3.5 AstraZeneca Plc Recent Development
11.4 Daiichi Sankyo Co Ltd
11.4.1 Daiichi Sankyo Co Ltd Company Detail
11.4.2 Daiichi Sankyo Co Ltd Business Overview
11.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Introduction
11.4.4 Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.4.5 Daiichi Sankyo Co Ltd Recent Development
11.5 Dompe Farmaceutici SpA
11.5.1 Dompe Farmaceutici SpA Company Detail
11.5.2 Dompe Farmaceutici SpA Business Overview
11.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Introduction
11.5.4 Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.5.5 Dompe Farmaceutici SpA Recent Development
11.6 Genzyme Corp
11.6.1 Genzyme Corp Company Detail
11.6.2 Genzyme Corp Business Overview
11.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Introduction
11.6.4 Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.6.5 Genzyme Corp Recent Development
11.7 Handok Inc
11.7.1 Handok Inc Company Detail
11.7.2 Handok Inc Business Overview
11.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Introduction
11.7.4 Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.7.5 Handok Inc Recent Development
11.8 Ignyta Inc
11.8.1 Ignyta Inc Company Detail
11.8.2 Ignyta Inc Business Overview
11.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Introduction
11.8.4 Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.8.5 Ignyta Inc Recent Development
11.9 Loxo Oncology Inc
11.9.1 Loxo Oncology Inc Company Detail
11.9.2 Loxo Oncology Inc Business Overview
11.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Introduction
11.9.4 Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.9.5 Loxo Oncology Inc Recent Development
11.10 Merck & Co Inc
11.10.1 Merck & Co Inc Company Detail
11.10.2 Merck & Co Inc Business Overview
11.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Introduction
11.10.4 Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.10.5 Merck & Co Inc Recent Development
11.11 Nerviano Medical Sciences Srl
11.11.1 Nerviano Medical Sciences Srl Company Detail
11.11.2 Nerviano Medical Sciences Srl Business Overview
11.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Introduction
11.11.4 Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.11.5 Nerviano Medical Sciences Srl Recent Development
11.12 Plexxikon Inc
11.12.1 Plexxikon Inc Company Detail
11.12.2 Plexxikon Inc Business Overview
11.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Introduction
11.12.4 Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.12.5 Plexxikon Inc Recent Development
11.13 Proximagen Ltd
11.13.1 Proximagen Ltd Company Detail
11.13.2 Proximagen Ltd Business Overview
11.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Introduction
11.13.4 Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.13.5 Proximagen Ltd Recent Development
11.14 Rottapharm Biotech Srl
11.14.1 Rottapharm Biotech Srl Company Detail
11.14.2 Rottapharm Biotech Srl Business Overview
11.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Introduction
11.14.4 Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.14.5 Rottapharm Biotech Srl Recent Development
11.15 Sienna Biopharmaceuticals Inc
11.15.1 Sienna Biopharmaceuticals Inc Company Detail
11.15.2 Sienna Biopharmaceuticals Inc Business Overview
11.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Introduction
11.15.4 Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.15.5 Sienna Biopharmaceuticals Inc Recent Development
11.16 Tiziana Life Sciences Plc
11.16.1 Tiziana Life Sciences Plc Company Detail
11.16.2 Tiziana Life Sciences Plc Business Overview
11.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Introduction
11.16.4 Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2018-2023)
11.16.5 Tiziana Life Sciences Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned: 

Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-high-affinity-nerve-growth-factor-receptor-market-research-report-2023

Links
[1] /countries/global[2] /healthcare[3] /pharma-healthcare